Newsroom

Group of people discussing research findings
News
Liver transplants often save the lives of seriously ill patients. However, there remains a risk that the body will reject the new organ. Doctors distinguish between acute and chronic rejection. While acute rejection is easy to diagnose and treat, chronic rejection causes lasting damage to the organ, is difficult to detect – currently only possible by examining tissue samples under a microscope – and is often overlooked. An international research team led by Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI) has now discovered clear molecular signatures for chronic rejection even after liver transplantation, which could aid diagnosis. After ten years of work, the findings have now been published in the Journal of Hepatology.
24.11.2025
Poster for the HZI in the Science Showcase from December 3-17; topic: "Mikrokosmos ganz groß"
News
To mark its 60th anniversary, the Helmholtz Centre for Infection Research (HZI) is bringing its research to the heart of Braunschweig's city center from 3 to 17 December 2025. Under the motto “Bringing science to life where people spend their everyday lives ”, the HZI is presenting an interactive exhibition, hands-on stations, offers for school classes in cooperation with the BioS school laboratory and exciting after-work talks with experts from the HZI in the science showcase ("Wissenschaftsschaufenster") at Waisenhausdamm 8.
20.11.2025
Group picture of 6 people with an oversized cheque
News
A novel oral immunotherapy for cancer and a drug for treating chronic liver fibrosis: What many patients are hoping for is already a part of cutting-edge research in Lower Saxony. To ensure that such innovative ideas are translated into practical applications more quickly, the state of Lower Saxony is funding particularly promising projects: “Citrapeutics” from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and “RNA Healer” from the Hannover Medical School (MHH) will receive a total of nearly €2.5 million in funding from the Institute for Biomedical Translation (IBT) Lower Saxony to spur their innovations.
19.11.2025
banner of the WHO
News
In Germany, around 10,000 people die every year from antibiotic-resistant pathogens. At the Helmholtz Centre for Infection Research (HZI) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), scientists are using artificial intelligence to find new antibiotics. In particular, they are looking for active substances that circumvent known resistance mechanisms. They are supported by citizen scientists sending them soil samples from various habitats. On the occasion of World Antimicrobial Resistance Awareness Week 2025, the Helmholtz Association explains how the researchers are fighting against multi-resistant germs.
18.11.2025
Portrait Dr. Felix Deschner and Dr. Max Kellner with their prizes
News
PhD students play a crucial role in the advancement of knowledge and technologies that shape our world. At the Helmholtz Centre for Infection Research (HZI) in Braunschweig and its locations, more than 300 doctoral students are working on solving important questions in infection research. Two HZI scientists have now been honored for their successful doctoral theses. Dr. Felix Deschner, postdoc at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), was awarded the Eduard Martin Prize of Saarland University. HZI junior research group leader Dr. Max Kellner received the PhD Award of the Vienna BioCenter for his doctoral thesis at the Institute of Molecular Biotechnology (IMBA) in Vienna.
17.11.2025
[Translate to English:] Rasterelektronenmikroskopische Aufnahme einer Escherichia coli-Zelle (rot), die von Bakteriophagen (grün) infiziert wird.
Story
Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in the first place. But their success has a downside: More and more bacteria are developing strategies to evade the attacks of these drugs. Resistant germs are spreading around the globe, against which hardly any drugs are effective. With the annual World Antimicrobial Resistance Awareness Week (WAAW) from 18 to 24 November, the World Health Organization reminds us how important it is to use antibiotics carefully and how urgently new approaches are needed to continue fighting infections effectively in the future. Almost 20 research groups in the research topic “Novel Anti-Infectives” at the Helmholtz Centre for Infection Research (HZI) are developing new drugs against infectious diseases.
17.11.2025

HZI in the media

... “ Außerdem erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in ...

21.11.2025
|
Medizinische Hochschule Hannover

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025
|
Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025
|
Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025
|
Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025
|
Rheinische Post

... Forschungsschwerpunkt „Neue Antiinfektiva“ des Helmholtz-Zentrums für Infektionsforschung (HZI) entwickeln fast 20 Forschungsgruppen neue ...

18.11.2025
|
Regional Heute

... , Stellvertretende Teamleiterin der Klinischen Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig.

17.11.2025
|
Biermann Medizin

... und individueller Darmflora ab.

 

Forscher am Helmholtz-Zentrum für Infektionsforschung arbeiten bereits an der nächsten Generation ...

14.11.2025
|
Ad Hoc News

Klett-Tammen, Abteilung Epidemiologie (EPID), Helmholtz-Zentrum für Infektionsforschung (

 

HZI

 

), Braunschweig. Grundsätzlich sei auch die ...

13.11.2025
|
Deutsches Ärzteblatt

von Angios in Innsbruck & wissenschaftlicher Geschäftsführer Helmholtz-Zentrum für Infektionsforschung in Braunschweig/Deutschland), Klaus

13.11.2025
|
meinbezirk.at

... zu adressieren, suchen Forschende am HZI-Standort Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) im Rahmen ...

13.11.2025
|
Prophylaxe Journal

new antiviral medicines, says virologist Christian Sieben of the Helmholtz Centre for Infection Research in Germany.

 

Earlier in 2025, for

10.11.2025
|
The Press

Register now for the HZI-Newsletter